RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Hialeah, FL · Jacksonville, FL · Kissimmee, FL · +37 more sites
2 recruiting ulcerative colitis studies with a site in Margate, FL.
Sponsor: Eli Lilly and Company
Hialeah, FL · Jacksonville, FL · Kissimmee, FL · +37 more sites
Sponsor: Xencor, Inc.
Bradenton, FL · Brandon, FL · Jacksonville, FL · +27 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.